Coloplast A/S

CPSE:COLO B Stock Report

Market Cap: kr.201.4b

Coloplast Past Earnings Performance

Past criteria checks 4/6

Coloplast has been growing earnings at an average annual rate of 5%, while the Medical Equipment industry saw earnings growing at 5.5% annually. Revenues have been growing at an average rate of 8.1% per year. Coloplast's return on equity is 32.2%, and it has net margins of 19.5%.

Key information

5.0%

Earnings growth rate

4.8%

EPS growth rate

Medical Equipment Industry Growth-1.7%
Revenue growth rate8.1%
Return on equity32.2%
Net Margin19.5%
Next Earnings Update07 May 2024

Recent past performance updates

Coloplast (CPH:COLO B) Strong Profits May Be Masking Some Underlying Issues

Nov 16
Coloplast (CPH:COLO B) Strong Profits May Be Masking Some Underlying Issues

Recent updates

There's Reason For Concern Over Coloplast A/S' (CPH:COLO B) Price

Apr 08
There's Reason For Concern Over Coloplast A/S' (CPH:COLO B) Price

Is Coloplast (CPH:COLO B) A Risky Investment?

Mar 21
Is Coloplast (CPH:COLO B) A Risky Investment?

Estimating The Intrinsic Value Of Coloplast A/S (CPH:COLO B)

Jan 09
Estimating The Intrinsic Value Of Coloplast A/S (CPH:COLO B)

Coloplast A/S' (CPH:COLO B) Price Is Out Of Tune With Earnings

Dec 22
Coloplast A/S' (CPH:COLO B) Price Is Out Of Tune With Earnings

These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Dec 04
These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Coloplast (CPH:COLO B) Strong Profits May Be Masking Some Underlying Issues

Nov 16
Coloplast (CPH:COLO B) Strong Profits May Be Masking Some Underlying Issues

A Look At The Intrinsic Value Of Coloplast A/S (CPH:COLO B)

Sep 30
A Look At The Intrinsic Value Of Coloplast A/S (CPH:COLO B)

Is Coloplast (CPH:COLO B) A Risky Investment?

Jun 28
Is Coloplast (CPH:COLO B) A Risky Investment?

Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 18% Below Its Share Price

Jun 10
Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 18% Below Its Share Price

Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly

Mar 22
Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly

Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 25% Below Its Share Price

Mar 01
Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 25% Below Its Share Price

These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Dec 14
These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Coloplast's (CPH:COLO B) Upcoming Dividend Will Be Larger Than Last Year's

Nov 26
Coloplast's (CPH:COLO B) Upcoming Dividend Will Be Larger Than Last Year's

Here's Why We Think Coloplast A/S' (CPH:COLO B) CEO Compensation Looks Fair for the time being

Nov 25
Here's Why We Think Coloplast A/S' (CPH:COLO B) CEO Compensation Looks Fair for the time being

Coloplast's (CPH:COLO B) Shareholders Will Receive A Bigger Dividend Than Last Year

Nov 11
Coloplast's (CPH:COLO B) Shareholders Will Receive A Bigger Dividend Than Last Year

With EPS Growth And More, Coloplast (CPH:COLO B) Makes An Interesting Case

Oct 25
With EPS Growth And More, Coloplast (CPH:COLO B) Makes An Interesting Case

Estimating The Fair Value Of Coloplast A/S (CPH:COLO B)

Aug 26
Estimating The Fair Value Of Coloplast A/S (CPH:COLO B)

These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Jul 27
These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Here's Why We Think Coloplast (CPH:COLO B) Is Well Worth Watching

Jul 12
Here's Why We Think Coloplast (CPH:COLO B) Is Well Worth Watching

Is There An Opportunity With Coloplast A/S' (CPH:COLO B) 45% Undervaluation?

May 23
Is There An Opportunity With Coloplast A/S' (CPH:COLO B) 45% Undervaluation?

Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of kr.5.00

May 08
Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of kr.5.00

Coloplast (CPH:COLO B) Seems To Use Debt Rather Sparingly

Apr 13
Coloplast (CPH:COLO B) Seems To Use Debt Rather Sparingly

Here's Why I Think Coloplast (CPH:COLO B) Is An Interesting Stock

Mar 29
Here's Why I Think Coloplast (CPH:COLO B) Is An Interesting Stock

Coloplast A/S (CPH:COLO B) Shares Could Be 41% Below Their Intrinsic Value Estimate

Feb 12
Coloplast A/S (CPH:COLO B) Shares Could Be 41% Below Their Intrinsic Value Estimate

Coloplast (CPH:COLO B) Could Easily Take On More Debt

Jan 12
Coloplast (CPH:COLO B) Could Easily Take On More Debt

Is Now The Time To Put Coloplast (CPH:COLO B) On Your Watchlist?

Dec 28
Is Now The Time To Put Coloplast (CPH:COLO B) On Your Watchlist?

Why We Think Coloplast A/S' (CPH:COLO B) CEO Compensation Is Not Excessive At All

Nov 25
Why We Think Coloplast A/S' (CPH:COLO B) CEO Compensation Is Not Excessive At All

A Look At The Fair Value Of Coloplast A/S (CPH:COLO B)

Oct 31
A Look At The Fair Value Of Coloplast A/S (CPH:COLO B)

Here's Why Coloplast (CPH:COLO B) Can Manage Its Debt Responsibly

Oct 02
Here's Why Coloplast (CPH:COLO B) Can Manage Its Debt Responsibly

Do Coloplast's (CPH:COLO B) Earnings Warrant Your Attention?

Sep 16
Do Coloplast's (CPH:COLO B) Earnings Warrant Your Attention?

Does This Valuation Of Coloplast A/S (CPH:COLO B) Imply Investors Are Overpaying?

Aug 02
Does This Valuation Of Coloplast A/S (CPH:COLO B) Imply Investors Are Overpaying?

Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly

Jul 01
Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly

Does Coloplast (CPH:COLO B) Deserve A Spot On Your Watchlist?

Jun 16
Does Coloplast (CPH:COLO B) Deserve A Spot On Your Watchlist?

Coloplast A/S (CPH:COLO B) Shares Could Be 34% Above Their Intrinsic Value Estimate

May 02
Coloplast A/S (CPH:COLO B) Shares Could Be 34% Above Their Intrinsic Value Estimate

Would Coloplast A/S (CPH:COLO B) Be Valuable To Income Investors?

Apr 11
Would Coloplast A/S (CPH:COLO B) Be Valuable To Income Investors?

Here's Why Coloplast (CPH:COLO B) Can Manage Its Debt Responsibly

Mar 29
Here's Why Coloplast (CPH:COLO B) Can Manage Its Debt Responsibly

Will Weakness in Coloplast A/S' (CPH:COLO B) Stock Prove Temporary Given Strong Fundamentals?

Mar 16
Will Weakness in Coloplast A/S' (CPH:COLO B) Stock Prove Temporary Given Strong Fundamentals?

I Built A List Of Growing Companies And Coloplast (CPH:COLO B) Made The Cut

Mar 02
I Built A List Of Growing Companies And Coloplast (CPH:COLO B) Made The Cut

Did You Participate In Any Of Coloplast's (CPH:COLO B) Fantastic 123% Return ?

Feb 17
Did You Participate In Any Of Coloplast's (CPH:COLO B) Fantastic 123% Return ?

What Percentage Of Coloplast A/S (CPH:COLO B) Shares Do Insiders Own?

Feb 03
What Percentage Of Coloplast A/S (CPH:COLO B) Shares Do Insiders Own?

Revenue & Expenses Breakdown
Beta

How Coloplast makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

CPSE:COLO B Revenue, expenses and earnings (DKK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 2325,0014,8688,934889
30 Sep 2324,5004,7838,632872
30 Jun 2324,3334,7848,581858
31 Mar 2324,0744,8018,550864
31 Dec 2223,5154,6268,272877
30 Sep 2222,5794,7067,800866
30 Jun 2221,6204,7817,336856
31 Mar 2220,6064,7466,828819
31 Dec 2119,8574,8966,446774
30 Sep 2119,4264,8256,249755
30 Jun 2118,9164,5616,098723
31 Mar 2118,5004,3045,938720
31 Dec 2018,5704,2415,993725
30 Sep 2018,5444,1976,086708
30 Jun 2018,5723,9496,113698
31 Mar 2018,7524,0206,199691
31 Dec 1918,3303,9746,118680
30 Sep 1917,9393,8735,970692
30 Jun 1917,5554,1195,753686
31 Mar 1917,1813,9995,626671
31 Dec 1816,8153,8965,488663
30 Sep 1816,4493,8455,375640
30 Jun 1816,1953,8165,315619
31 Mar 1815,8823,7785,211605
31 Dec 1715,7283,7915,104594
30 Sep 1715,5283,7974,994574
30 Jun 1715,2873,2114,880565
31 Mar 1715,0613,2794,785551
31 Dec 1614,7803,2644,731521
30 Sep 1614,6813,1434,693509
30 Jun 1614,5631,2974,690494
31 Mar 1614,4171,0284,627477
31 Dec 1514,2649274,583458
30 Sep 1513,9098994,488442
30 Jun 1513,5023,1624,343437
31 Mar 1513,0963,2414,220418
31 Dec 1412,6662,4074,088406
30 Sep 1412,4282,3904,002390
30 Jun 1412,1842,2983,959375
31 Mar 1412,0082,2203,944370
31 Dec 1311,8332,8743,889382
30 Sep 1311,6352,7113,854380
30 Jun 1311,5142,5703,937371

Quality Earnings: COLO B has high quality earnings.

Growing Profit Margin: COLO B's current net profit margins (19.5%) are lower than last year (19.7%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: COLO B's earnings have grown by 5% per year over the past 5 years.

Accelerating Growth: COLO B's earnings growth over the past year (5.2%) exceeds its 5-year average (5% per year).

Earnings vs Industry: COLO B earnings growth over the past year (5.2%) exceeded the Medical Equipment industry 2.4%.

Return on Equity

High ROE: Whilst COLO B's Return on Equity (32.19%) is high, this metric is skewed due to their high level of debt.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.